OneSource receives equity commitments of Rs 8,010 Mn at a pre-money equity valuation of $ 1.65 Bn Read more
International life sciences regulations: How CROs, CMOs, and CDMOs are primed for advantage Read more
Zydus, ICMR initiate Phase 2 clinical trial of Desidustat in patients with Sickle Cell Disease Read more
Accord BioPharma’s Biosimilar IMULDOSA gains USFDA approval for treatment of chronic inflammatory conditions Read more